Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: a prospective, randomized, crossover study.
Authors:
- S SaksenaSSS Saksena
- P ChandranPCP Chandran
- Y ShahYSY Shah
- R BoccadamoRBR Boccadamo
- D PantopoulosDPD Pantopoulos
- S T RothbartSRS T Rothbart
- 1 July 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 72 (1) , 153-160
Abstract
We performed a prospective, randomized crossover study to evaluate the comparative efficacy of transvenous cardioversion and rapid ventricular pacing for termination of induced ventricular tachycardia in patients with spontaneous ventricular tachycardia and organic heart disease. Sixty-two episodes of ventricular tachycardia were induced in 15 patients, mean age 60 +/- 10 years, during electrophysiologic studies. All patients underwent a preselected electrical therapy protocol in a randomized crossover sequence. Transvenous cardioversion was performed by an incremental protocol of three sequential shocks (0.5, 1.1, and 2.7 J). Six asynchronous sequential bursts of rapid ventricular pacing (10 and 15 paced stimuli at 90%, 75%, and 65% of ventricular tachycardia cycle length) were used. Mean cycle length of ventricular tachycardia for the study population was 391 +/- 85 msec. The morphology of the tachycardia was left bundle branch block in 27, right bundle branch block in 32, and indeterminate in three. Characteristics of ventricular tachycardia terminated by the two techniques were comparable. Rate of success for termination of tachycardia with the two methods was also comparable (transvenous cardioversion 83%, rapid ventricular pacing 80%; p greater than .1) and these responses were concordant in 78%. The modes of termination of ventricular tachycardia were similar. The incidence of acceleration of ventricular tachycardia per episode with these preselected protocols was also comparable (transvenous cardioversion 11%, rapid ventricular pacing 6%; p greater than .2). Transient supraventricular tachyarrhythmias were more frequent after transvenous cardioversion (23%) than after rapid ventricular pacing (3%). Significant patient discomfort occurred only after transvenous cardioversion (incidence of 57%).(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 15 references indexed in Scilit:
- Early Experience with an Implantable CardioverterNew England Journal of Medicine, 1984
- Management of recurrent ventricular tachycardia: Economic impact of therapeutic alternativesThe American Journal of Cardiology, 1984
- Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardiaJACC, 1983
- Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardiaAmerican Heart Journal, 1983
- The sparkling joules of internal cardiac stimulation: Cardioversion, defibrillation, and ablationAmerican Heart Journal, 1982
- Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrodeAmerican Heart Journal, 1982
- Transient Entrainment and Interruption of Ventricular TachycardiaPacing and Clinical Electrophysiology, 1981
- Patient-activated transvenous cardiac stimulation for the treatment of supraventricular and ventricular tachycardiaThe American Journal of Cardiology, 1981
- Permanent radiofrequency ventricular pacing for management of drug-resistant ventricular tachycardiaThe American Journal of Cardiology, 1980
- Termination of ventricular tachycardia with bursts of rapid ventricular pacingThe American Journal of Cardiology, 1978